Usefulness of Measuring microRNAs in Bile and Plasma for Pancreatic Ductal Adenocarcinoma Diagnosis

Affiliations

¹ 1] Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
² Department of Surgery and Cancer, Imperial College, London, UK.
³ Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands.
⁴ 1] Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands [2] AIRC Start-Up Unit, University of Pisa, Pisa, Italy.

Comment

Tessa Y S Le Large et al. Am J Gastroenterol. 2015 May.

. 2015 May;110(5):768-9.

doi: 10.1038/ajg.2015.77.

¹ 1] Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
² Department of Surgery and Cancer, Imperial College, London, UK.
³ Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands.
⁴ 1] Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands [2] AIRC Start-Up Unit, University of Pisa, Pisa, Italy.

No abstract available

Comment in

Response to Le Large et al.
Cote GA, Gore AJ, McElyea SD, Xu H, Sherman S, Korc M. Cote GA, et al. Am J Gastroenterol. 2015 May;110(5):769-70. doi: 10.1038/ajg.2015.82. Am J Gastroenterol. 2015. PMID: 25942303 No abstract available.

A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S, Korc M. Cote GA, et al. Am J Gastroenterol. 2014 Dec;109(12):1942-52. doi: 10.1038/ajg.2014.331. Epub 2014 Oct 28. Am J Gastroenterol. 2014. PMID: 25350767 Free PMC article.